Hongxiao Li Selected Research

ophiopogonin B

1/2021	Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin.
1/2019	Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongxiao Li Research Topics

Disease

4	Neoplasms (Cancer) 08/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
1	Diabetic Foot 04/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Ulcer 04/2022
1	Inflammation (Inflammations) 04/2022
1	Polyploidy 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	ST Elevation Myocardial Infarction 01/2020
1	Myocardial Infarction 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Adenocarcinoma of Lung 01/2019
1	Adenocarcinoma 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Leukopenia 01/2019

Drug/Important Bio-Agent (IBA)

2	ophiopogonin BIBA 01/2021 - 01/2019
1	Lysine (L-Lysine)FDA Link 08/2022
1	Histones (Histone)IBA 08/2022
1	histone H3 trimethyl Lys4IBA 08/2022
1	phytobacteriomycin (PBM)IBA 04/2022
1	CollagenIBA 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	SaponinsIBA 01/2021
1	CateninsIBA 01/2021
1	Sodium Chloride FDA LinkGeneric 01/2020
1	Troponin IIBA 01/2020
1	lauroyl-alpha-hydroxyethyl sulfonic acidIBA 04/2019
1	PlatinumIBA 01/2019

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Therapeutics 04/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Percutaneous Coronary Intervention 01/2020